P. Bryant

Symmetry-based inhibitors of HIV protease. Structure-activity studies of acylated 2,4-diamino-1,5-diphenyl-3-hydroxypentane and 2,5-diamino-1,6-diphenylhexane-3,4-diol.

S. Vasavanonda, D. Kempf, H. Sham, 1993, Journal of medicinal chemistry.

Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease

S. Vasavanonda, D. Norbeck, D. Kempf, 1991, Antimicrobial Agents and Chemotherapy.

Design of orally bioavailable, symmetry-based inhibitors of HIV protease.

S. Vasavanonda, D. Kempf, H. Sham, 1994, Bioorganic & medicinal chemistry.